111 related articles for article (PubMed ID: 3752946)
1. Protective effect of L-carnitine on cardiac metabolic damage induced by doxorubicin in vitro.
Neri B; Cini-Neri G; Bartalucci S; Bandinelli M
Anticancer Res; 1986; 6(4):659-62. PubMed ID: 3752946
[TBL] [Abstract][Full Text] [Related]
2. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
Cini-Neri G; Neri B
Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin plus lonidamine: in vivo metabolic effects on the rat heart.
Neri B; Lottini G; Bandinelli E; Cini-Neri G
Anticancer Drugs; 1991 Aug; 2(4):401-4. PubMed ID: 1797197
[TBL] [Abstract][Full Text] [Related]
4. Synergic and complementary effects of L-carnitine and coenzyme Q on long-chain fatty acid metabolism and on protection against anthracycline damage.
Conte A; Palmieri L; Ronca G; Giovannini L; Bertelli A
Int J Tissue React; 1990; 12(3):197-201. PubMed ID: 2276901
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model.
Sayed-Ahmed MM; Al-Shabanah OA; Hafez MM; Aleisa AM; Al-Rejaie SS
Eur J Pharmacol; 2010 Aug; 640(1-3):143-9. PubMed ID: 20470772
[TBL] [Abstract][Full Text] [Related]
6. Differences between carnitine derivatives and coenzyme Q10 in preventing in vitro doxorubicin-related cardiac damages.
Neri B; Neri GC; Bandinelli M
Oncology; 1988; 45(3):242-6. PubMed ID: 3368201
[TBL] [Abstract][Full Text] [Related]
7. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
[TBL] [Abstract][Full Text] [Related]
8. Carnitine prevention of adriamycin toxicity in mice.
Alberts DS; Peng YM; Moon TE; Bressler R
Biomedicine; 1978 Nov; 29(8):265-8. PubMed ID: 743560
[TBL] [Abstract][Full Text] [Related]
9. Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine.
Sayed-Ahmed MM; Shaarawy S; Shouman SA; Osman AM
Pharmacol Res; 1999 Apr; 39(4):289-95. PubMed ID: 10208759
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
Strauss M; Porras N
Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542
[TBL] [Abstract][Full Text] [Related]
11. Protective action of L-carnitine on cardiac mitochondrial function and structure against fatty acid stress.
Oyanagi E; Yano H; Uchida M; Utsumi K; Sasaki J
Biochem Biophys Res Commun; 2011 Aug; 412(1):61-7. PubMed ID: 21791201
[TBL] [Abstract][Full Text] [Related]
12. Effect of carnitine and coenzyme Q10 on the calcium uptake in heart sarcoplasmic reticulum of rats treated with anthracyclines.
Ronca-Testoni S; Zucchi R; Ronca F; Bertelli A
Drugs Exp Clin Res; 1992; 18(10):437-42. PubMed ID: 1306157
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer.
Maccari F; Ramacci MT
Biomedicine; 1981 May; 35(2):65-7. PubMed ID: 7260239
[TBL] [Abstract][Full Text] [Related]
14. L-Carnitine suppresses oleic acid-induced membrane permeability transition of mitochondria.
Oyanagi E; Yano H; Kato Y; Fujita H; Utsumi K; Sasaki J
Cell Biochem Funct; 2008 Oct; 26(7):778-86. PubMed ID: 18683897
[TBL] [Abstract][Full Text] [Related]
15. L-carnitine prevents increase in diastolic [CA2+] induced by doxorubicin in cardiac cells.
Mijares A; López JR
Eur J Pharmacol; 2001 Aug; 425(2):117-20. PubMed ID: 11502276
[TBL] [Abstract][Full Text] [Related]
16. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
[TBL] [Abstract][Full Text] [Related]
17. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation.
Andrieu-Abadie N; Jaffrezou JP; Hatem S; Laurent G; Levade T; Mercadier JJ
FASEB J; 1999 Sep; 13(12):1501-10. PubMed ID: 10463940
[TBL] [Abstract][Full Text] [Related]
18. Protection of adenylate pool and energy charge by L-carnitine and coenzyme Q during energy depletion in rat heart slices.
Conte A; Palmieri L; Ronca G; Giovannini L; Bertelli A
Int J Tissue React; 1990; 12(3):187-91. PubMed ID: 2276899
[TBL] [Abstract][Full Text] [Related]
19. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
Zhou S; Heller LJ; Wallace KB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):60-7. PubMed ID: 11509027
[TBL] [Abstract][Full Text] [Related]
20. [Effect of carnitine on energy processes in the myocardium of rats].
Makarova VG
Farmakol Toksikol; 1985; 48(2):57-9. PubMed ID: 3996572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
